Clinical performance and biocompatibility of hyaluronan-based heparin-bonded extracorporeal circuits in different risk cohorts (original) (raw)

Synthetic protein treated versus heparin coated cardiopulmonary bypass surfaces: similar clinical results and minor biochemical differences

Anton Moritz

European Journal of Cardio-Thoracic Surgery, 1999

View PDFchevron_right

Do surface modifying additives (SMA) influence blood loss and thrombogenicity in conventional cardiopulmonary bypass for coronary artery bypass grafting?

Mirko Doss

Cardiovascular Surgery, 2003

View PDFchevron_right

Heparin-coated cardiopulmonary bypass equipment. I. Biocompatibility markers and development of complications in a high-risk population

E. Fosse

The Journal of Thoracic and Cardiovascular Surgery, 1999

View PDFchevron_right

Comparison of a Duraflo II-coated cardiopulmonary bypass circuit and a trillium-coated oxygenator during open-heart surgery

Frank Brosstad

Perfusion, 2004

View PDFchevron_right

Biocompatibility of Heparin-Coated Cardiopulmonary Bypass Circuits in Coronary Patients With Left Ventricular Dysfunction Is Superior to PMEA-Coated Circuits

Tevfik Noyan

Journal of Cardiac Surgery, 2006

View PDFchevron_right

Humoral immune response and coated or uncoated oxygenators during cardiopulmonary bypass surgery

Gokhan Ilhan

Cardiovascular Journal of Africa, 2016

View PDFchevron_right

Disparity in blood activation by two different heparin-coated cardiopulmonary bypass systems

Per Venge

The Annals of Thoracic Surgery, 1995

View PDFchevron_right

Changes in Platelet, Granulocyte, and Complement Activation During Cardiopulmonary Bypass Using Heparin-coated Equipment

Soichiro Kitamura

Artificial Organs, 1996

View PDFchevron_right

Heparin-coated cardiopulmonary bypass circuits: Hemostatic alterations and postoperative blood loss

Peter Johnson

Annals of Thoracic Surgery, 1994

View PDFchevron_right

A Biocompatible Cardiopulmonary Bypass Strategy to Reduce Hemostatic and Inflammatory Alterations: A Randomized Controlled Trial

Domenico Paparella, Giuseppe Scrascia

Journal of Cardiothoracic and Vascular Anesthesia, 2012

View PDFchevron_right

Efficacy of a new coating material, PMEA, for cardiopulmonary bypass circuits in a porcine model

Motonobu Nishimura

The Annals of Thoracic Surgery, 2001

View PDFchevron_right

The Impact of Heparin-coated Circuits on Hemodynamics During and After Cardiopulmonary Bypass

Erik Hack

Artificial Organs, 2005

View PDFchevron_right

Tissue factor as the main activator of the coagulation system during cardiopulmonary bypass

filip de somer

Journal of Thoracic and Cardiovascular Surgery, 2002

View PDFchevron_right

Experimental Research With Synthetic Copolymer-Coated Cardiopulmonary Bypass Circuits: Inflammatory and Thrombogenicity Analysis

Valeria Chida

Artificial Organs, 2012

View PDFchevron_right

IL-6 and IL-8 levels after cardiopulmonary bypass are not affected by surface coating

Clarke Thuys, S. Horton, Christian Brizard

The Annals of Thoracic Surgery, 1999

View PDFchevron_right

Poly-2-methoxyethylacrylate-coated bypass circuits reduce activation of coagulation system and inflammatory response in congenital cardiac surgery

Ikuo Fukuda

Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs, 2008

View PDFchevron_right

Effect of cardiopulmonary bypass on hemostasis in patients undergoing cardiac surgery

Heemel Saha

Bangabandhu Sheikh Mujib Medical University Journal, 2018

View PDFchevron_right

Phosphorylcholine Coating May Limit Thrombin Formation During High-Risk Cardiac Surgery: A Randomized Controlled Trial

Lucia Torracca

The Annals of Thoracic Surgery, 2006

View PDFchevron_right

Phosphorylcholine-coated extracoporeal circulation systems affect coagulation factors during cardiopulmonary bypass insufficiently: a preliminary report

Mustafa Canikoglu, Ali Hatemi

Turkish Journal of Thoracic and Cardiovascular Surgery, 2014

View PDFchevron_right

Recent advances in biocompatible surface-modifying additives for cardiopulmonary bypass

Kevin McCusker

Perfusion, 2003

View PDFchevron_right

Duraflo II coating of cardiopulmonary bypass circuits reduces complement activation, but does not affect the release of granulocyte enzymes in fully heparinized patients: a European multicentre study

Jan Ludvig Svennevig

European Journal of Cardio-Thoracic Surgery, 1997

View PDFchevron_right